Drugs that contain Donepezil Hydrochloride
1. Adlarity patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11679086 | CORIUM | Systems comprising a composite backing and methods for long term transdermal administration |
May, 2037
(13 years from now) | |
| US11103463 | CORIUM | Methods for treating alzheimer's disease with donepezil transdermal system |
Jul, 2037
(13 years from now) | |
| US10016372 | CORIUM | Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery |
Jul, 2037
(13 years from now) | |
| US10300025 | CORIUM | Donepezil transdermal delivery system |
Jul, 2037
(13 years from now) | |
| US9993466 | CORIUM | Donepezil transdermal delivery system |
Jul, 2037
(13 years from now) | |
| US10307379 | CORIUM | Donepezil transdermal delivery system |
Jul, 2037
(13 years from now) | |
| US11648214 | CORIUM | Systems and methods for long term transdermal administration |
Sep, 2037
(13 years from now) | |
| US10835499 | CORIUM | Systems and methods for long term transdermal administration |
May, 2038
(14 years from now) | |
| US10966936 | CORIUM | Systems comprising a composite backing and methods for long term transdermal administration |
Aug, 2038
(14 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Mar 11, 2025 |
Market Authorisation Date: 11 March, 2022
Treatment: A method of transdermal delivery of donepezil for treating mild, moderate and severe dementia of the alzheimer's type
Dosage: SYSTEM;TRANSDERMAL
More Information on Dosage
ADLARITY family patents
2. Aricept patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5985864 | EISAI INC | Polymorphs of donepezil hydrochloride and process for production |
Dec, 2016
(7 years ago) | |
| US6140321 | EISAI INC | Polymorphs of donepezil hydrochloride and process for production |
Dec, 2016
(7 years ago) | |
| US6245911 | EISAI INC | Donepezil polycrystals and process for producing the same |
Dec, 2018
(5 years ago) | |
| US8481565 | EISAI INC | Method for stabilizing anti-dementia drug |
Oct, 2026
(2 years from now) | |
Market Authorisation Date: 25 November, 1996
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of ARICEPT before it's drug patent expiration?
More Information on Dosage
ARICEPT family patents
3. Aricept Odt patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7727552 | EISAI INC | Oral pharmaceutical preparations decreased in bitterness by masking |
Mar, 2018
(6 years ago) | |
| US7727548 | EISAI INC | Rapidly disintegrable tablet containing polyvinyl alcohol |
Jun, 2022
(1 year, 9 months ago) | |
Market Authorisation Date: 18 October, 2004
Treatment: Administration of approved product for treatment of alzheimer's disease
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
How can I launch a generic of ARICEPT ODT before it's drug patent expiration?
More Information on Dosage
ARICEPT ODT family patents